Orchestra Biomed Holdings, INC Schedule 13G passive stakes

Medtronic plc and Covidien Group S.a.r.l. have jointly reported a beneficial ownership of 17.8% in Orchestra BioMed Holdings, Inc. common stock.

Tasso Partners, LLC and Dana Lorenzo have jointly filed a Schedule 13G, disclosing beneficial ownership of 5.5% of Orchestra BioMed Holdings, Inc.'s common stock.

Perceptive Advisors, Joseph Edelman, and Perceptive Life Sciences Master Fund collectively reported a 9.99% beneficial ownership stake in Orchestra BioMed Holdings, Inc.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 3.7% passive beneficial ownership stake in Orchestra BioMed Holdings, Inc. as of March 31, 2025.

Medtronic plc and its subsidiary Covidien Group S.a.r.l. have disclosed a combined beneficial ownership of 15.4% in Orchestra BioMed Holdings, Inc., holding 5,868,916 shares of common stock as of December 31, 2024.